FBTAX vs. IBB

In the year-to-date period, FBTAX achieves a -6.21% return, which is significantly lower than IBB's -5.62% return. Over the past 10 years, FBTAX has underperformed IBB with an annualized return of -0.44%, while IBB has yielded a comparatively higher 0.49% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FBTAX has a 1.00% expense ratio, which is higher than IBB's 0.47% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class A (FBTAX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FBTAX Sharpe Ratio is -0.43, which is comparable to the IBB Sharpe Ratio of -0.40. The chart below compares the historical Sharpe Ratios of FBTAX and IBB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FBTAX's dividend yield for the trailing twelve months is around 3.12%, more than IBB's 0.31% yield.

The maximum FBTAX drawdown since its inception was -60.08%, roughly equal to the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for FBTAX and IBB. For additional features, visit the drawdowns tool.

Fidelity Advisor Biotechnology Fund Class A (FBTAX) and iShares Nasdaq Biotechnology ETF (IBB) have volatilities of 10.12% and 10.22%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.